Contact this trialFirst, we need to learn more about you.
Alkylating agents
TAK-788 vs Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Charlottesville, Virginia
This trial will compare the effectiveness of TAK-788 to platinum-based chemotherapy in participants with NSCLC whose tumors have EGFR exon 20 insertion mutations.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service